Back to News

³Ô¹Ï±¬ÁÏ Vault CRM Selected by Biogen

Unified commercial platform to help speed the delivery of medicines to patients

PLEASANTON, CA ¡ª August 25, 2026 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced that Biogen has committed to ³Ô¹Ï±¬ÁÏ Vault CRM globally.

¡°We are honored to provide Vault CRM as the agentic commercial foundation for Biogen as it delivers medicines that transform patients¡¯ lives,¡± said Tom Schwenger, president and CCO at ³Ô¹Ï±¬ÁÏ. ¡°Bringing complex treatments to market requires a highly adaptive commercial strategy, and we are committed to providing the advanced capabilities needed to help accelerate patient impact around the world.¡±

¡°Biogen and ³Ô¹Ï±¬ÁÏ share a deep commitment to customer experience and innovation,¡± said Guy Hadari, senior vice president, global CIO at Biogen. ¡°We are excited to expand our strategic partnership with ³Ô¹Ï±¬ÁÏ by moving to Vault CRM.¡±

Vault CRM is part of the Vault CRM Suite which includes the Agentic Call Report to generate Commercial Evidence. These applications provide the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.

³Ô¹Ï±¬ÁÏ Forward-Looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Maria Scurry
³Ô¹Ï±¬ÁÏ Systems
maria.scurry@veeva.com

Meera Lakhani-Patel
³Ô¹Ï±¬ÁÏ Systems
meera.lakhani-patel@veeva.com

³Ô¹Ï±¬ÁÏ Commercial Summit, Europe

Copenhagen | 18¨C19 November, 2026

Register Now